Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Breast Neoplasms
×
4-hydroxy-N-desmethyltamoxifen
×
Clear all
Filters
3
NCT01042379
2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled
NCT05607004
2025-10-30
EVANGELINE
Atossa Therapeutics, Inc.
Phase 2
Recruiting
87 enrolled